69 related articles for article (PubMed ID: 11922706)
1. Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas.
Wharton SB; Chan KK; Whittle IR
J Clin Neurosci; 2002 Mar; 9(2):165-9. PubMed ID: 11922706
[TBL] [Abstract][Full Text] [Related]
2. J1-31 protein expression in astrocytes and astrocytomas.
Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
[TBL] [Abstract][Full Text] [Related]
3. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
5. Ras p21 expression in brain tumors: elevated expression in malignant astrocytomas and glioblastomas multiforme.
Arvanitis D; Malliri A; Antoniou D; Linardopoulos S; Field JK; Spandidos DA
In Vivo; 1991; 5(4):317-21. PubMed ID: 1667267
[TBL] [Abstract][Full Text] [Related]
6. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.
Gunal A; Onguru O; Safali M; Beyzadeoglu M
Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442
[TBL] [Abstract][Full Text] [Related]
7. Proteomic studies on low- and high-grade human brain astrocytomas.
Odreman F; Vindigni M; Gonzales ML; Niccolini B; Candiano G; Zanotti B; Skrap M; Pizzolitto S; Stanta G; Vindigni A
J Proteome Res; 2005; 4(3):698-708. PubMed ID: 15952716
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas.
Tuccari G; Giuffrè G; Crisafulli C; Barresi G
Eur J Histochem; 1999; 43(4):317-22. PubMed ID: 10682270
[TBL] [Abstract][Full Text] [Related]
9. Differential localization of high- and low-molecular-weight variants of microtubule-associated protein 2 in the developing rat telencephalon.
Fujimori K; Takauji R; Tamamaki N
J Comp Neurol; 2002 Aug; 449(4):330-42. PubMed ID: 12115669
[TBL] [Abstract][Full Text] [Related]
10. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
[TBL] [Abstract][Full Text] [Related]
11. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
[TBL] [Abstract][Full Text] [Related]
12. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
Sasaki T; Lopes MB; Hankins GR; Helm GA
Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
[TBL] [Abstract][Full Text] [Related]
13. High mobility group A1 expression correlates with the histological grade of human glial tumors.
Donato G; Martinez Hoyos J; Amorosi A; Maltese L; Lavano A; Volpentesta G; Signorelli F; Pentimalli F; Pallante P; Ferraro G; Tucci L; Signorelli CD; Viglietto G; Fusco A
Oncol Rep; 2004 Jun; 11(6):1209-13. PubMed ID: 15138557
[TBL] [Abstract][Full Text] [Related]
14. The expression of thyroid hormone receptor isoforms in human astrocytomas.
Hwang SL; Lin CL; Lieu AS; Hwang YF; Howng SL; Hong YR; Chang DS; Lee KS
Surg Neurol; 2008 Dec; 70 Suppl 1():S1:4-8; discussion S1:8. PubMed ID: 18617237
[TBL] [Abstract][Full Text] [Related]
15. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.
Hara A; Saegusa M; Ichinoe M; Okayasu I
J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430
[TBL] [Abstract][Full Text] [Related]
17. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
18. Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry.
Cao L; Cao W; Zhang W; Lin H; Yang X; Zhen H; Cheng J; Dong W; Huo J; Zhang X
Neurosci Lett; 2008 Feb; 432(2):94-9. PubMed ID: 18242847
[TBL] [Abstract][Full Text] [Related]
19. Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.
Nakamura M; Ishida E; Shimada K; Nakase H; Sakaki T; Konishi N
Acta Neuropathol; 2005 Oct; 110(4):402-10. PubMed ID: 16155764
[TBL] [Abstract][Full Text] [Related]
20. The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma.
Hidaka T; Hama S; Shrestha P; Saito T; Kajiwara Y; Yamasaki F; Sugiyama K; Kurisu K
Anticancer Res; 2009 Feb; 29(2):597-603. PubMed ID: 19331209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
